Candriam Equities L Biotechnology Class R2 Fonds
237,99
USD
+0,95
USD
+0,40
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 5,86% |
| Amgen Inc | US0311621009 | 5,33% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,23% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,68% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,34% |
| BioNTech SE ADR | US09075V1026 | 3,44% |
| argenx SE | NL0010832176 | 2,51% |
| Ascendis Pharma AS ADR | US04351P1012 | 2,35% |
| Insmed Inc | US4576693075 | 2,30% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,15% |
| Sonstige | 61,82% |